S. Nagashima

发表

The calcimimetic agent KRN 1493 lowers plasma parathyroid hormone and ionized calcium concentrations in patients with chronic renal failure on haemodialysis both on the day of haemodialysis and on the day without haemodialysis.

T. Akizawa, A. Hishida, N. Ohashi, 2004, British journal of clinical pharmacology.

Effects of SCH27899 (Ziracin), an oligosaccharide everninomicin antibiotic, on urate kinetics in humans

T. Hosoya, A. Hishida, K. Nishiki, 2004, European Journal of Clinical Pharmacology.

Cardiac and hemodynamic effects of TZC-5665, a novel pyridazinone derivative, and its metabolite in humans and dogs.

H. Ochiai, M. Nakashima, H. Hashimoto, 1997, General pharmacology.

Effects of DPI 201-106, a novel cardiotonic agent, on hemodynamics, cardiac electrophysiology and arrhythmias induced by programmed ventricular stimulation in dogs with subacute myocardial infarction: A comparative study with dobutamine

M. Nakashima, M. Nishimoto, T. Ozaki, 1991, Naunyn-Schmiedeberg's Archives of Pharmacology.

Photochemically induced thrombosis model in rat femoral artery and evaluation of effects of heparin and tissue-type plasminogen activator with use of this model.

M. Nakashima, H. Matsuno, T. Uematsu, 1991, Journal of pharmacological methods.

Antiarrhythmic effects of a benzothiazine derivative (SD-3211) and its stereoisomer (SA3212) in anaesthetized rats and isolated perfused rat hearts compared with bepridil

T. Uematsu, S. Nagashima, M. Fukuchi, 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

Pharmacokinetics of a New Parenteral Oligosaccharide Antibiotic, SCH27899 (Ziracin), in Healthy Subjects

O. Kozawa, M. Niwa, H. Matsuno, 2001, Antimicrobial Agents and Chemotherapy.

Antiarrhythmic and electrophysiological effects of SD-3212, a novel Na+ and Ca++ channel blocker, in anaesthetized dogs with myocardial infarction in comparison with its stereoisomer (SD-3211) and bepridil

M. Nakashima, H. Hashimoto, T. Uematsu, 1992, Naunyn-Schmiedeberg's Archives of Pharmacology.

Effects of antidepressants on the intraventricular conduction and the incidence of arrhythmias induced by programmed ventricular stimulation in the dog heart after myocardial infarction

M. Nakashima, M. Nishimoto, H. Hashimoto, 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

Pharmacokinetic and Pharmacodynamic Profiles of CS‐518, A Selective, Long‐Lasting Thromboxane Synthase Inhibitor, After Single and Multiple Oral Administration to Healthy Volunteers

M. Nakashima, K. Kosuge, H. Inaba, 1994, Journal of clinical pharmacology.

A fluorescence polarization immunoassay evaluated for quantifying astromicin, a new aminoglycoside antibiotic.

M. Nishimoto, T. Uematsu, S. Nagashima, 1988, Clinical chemistry.

Comparative antiplatelet effects of aspirin, vapiprost and GR144053, a GPIIb/IIIa antagonist, with a special reference to the role of platelet microaggregates

O. Kozawa, H. Matsuno, Toshihiko Uematsu, 1999, British journal of pharmacology.

Pharmacokinetic Study of an Oral Cephalosporin, Cefdinir, in Hemodialysis Patients

A. Hishida, M. Kanamaru, K. Ohishi, 1998, Antimicrobial Agents and Chemotherapy.

Pharmacokinetic and Pharmacodynamic Properties of a New Thromboxane Receptor Antagonist (Z‐335) after Single and Multiple Oral Administrations to Healthy Volunteers

O. Kozawa, M. Niwa, H. Matsuno, 2002, Journal of clinical pharmacology.

Pharmacokinetics and tolerability of intravenous infusion of adenosine (SUNY4001) in healthy volunteers.

O. Kozawa, M. Niwa, H. Matsuno, 2000, British journal of clinical pharmacology.

Comparison of the effects of pirmenol and lidocaine on intraventricular conduction in canine myocardial infarction.

M. Nakashima, H. Hashimoto, S. Nagashima, 1991, Journal of electrocardiology.

Influence of 7-day Hospitalization for Phase I Study on the Biochemical Laboratory Tests of Healthy Volunteers

M. Nakashima, M. Kanamaru, T. Uematsu, 1989 .

Comparative study of pharmacokinetics of two new fluoroquinolones, balofloxacin and grepafloxacin, in elderly subjects

O. Kozawa, M. Niwa, H. Matsuno, 1996, Antimicrobial agents and chemotherapy.

Prediction of pharmacokinetics of antibiotics in patients with end-stage renal disease.

A. Hishida, N. Tajima, H. Naganuma, 2006, Biological & pharmaceutical bulletin.

Influence of ALDH2 genetic polymorphisms on aciclovir pharmacokinetics following oral administration of valaciclovir in Japanese end-stage renal disease patients.

H. Itoh, K. Suyama, K. Hara, 2008, Drug metabolism and pharmacokinetics.

Pharmacokinetics of panipenem/betamipron in patients with end-stage renal disease

A. Hishida, N. Ohashi, A. Togawa, 2005, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Comparative effects of the antidepressants amitriptyline, mianserin and adinazolam on hemodynamics and ECG in myocardial infarcted dogs.

M. Nishimoto, M. Nakashima, H. Hashimoto, 1989, Archives internationales de pharmacodynamie et de therapie.

Pharmacokinetics and Safety of a New Parenteral Carbapenem Antibiotic, Biapenem (L-627), in Elderly Subjects

O. Kozawa, Y. Takiguchi, M. Niwa, 1998, Antimicrobial Agents and Chemotherapy.

Effect of dietary fat content on oral bioavailability of menatetrenone in humans.

T. Sassa, M. Niwa, Toshihiko Uematsu, 1996, Journal of pharmaceutical sciences.

Phase 1 study of L-627, biapenem, a new parenteral carbapenem antibiotic.

M. Nakashima, K. Kosuge, H. Inaba, 1993, International journal of clinical pharmacology, therapy, and toxicology.

Pharmacokinetic and Pharmacodynamic Profiles of Vapiprost, a Selective, Long‐Lasting Thromboxane Receptor Antagonist, After Single and Multiple Oral Administration to Healthy Volunteers

M. Nakashima, T Uematsu, M Nakashima, 1991, Journal of clinical pharmacology.

Ofloxacin in human hair determined by high performance liquid chromatography.

T. Uematsu, S. Nagashima, A. Mizuno, 1991, Forensic science international.

The axial distribution of nicotine content along hair shaft as an indicator of changes in smoking behaviour: evaluation in a smoking-cessation programme with or without the aid of nicotine chewing gum.

T. Uematsu, S. Nagashima, A. Mizuno, 1995, British journal of clinical pharmacology.

Pharmacokinetics and Safety of NZ-105 in Healthy Volunteers

M. Nakashima, M. Kanamaru, T. Uematsu, 1991 .

Pharmacokinetic and Pharmacodynamic Properties of Intravenous Darbepoetin Alfa (KRN321) in Japanese Hemodialysis Patients

T. Akizawa, N. Ohashi, E. Uchida, 2007 .

Design of a suitable formulation of FK613, a novel antiallergic agent, based on its pharmacokinetic and pharmacodynamic properties in healthy subjects

M. Nakashima, H. Inaba, A. Sugiyama, 2004, European Journal of Clinical Pharmacology.

Pharmacokinetics and safety of intravenous recombinant human superoxide dismutase (NK341) in healthy subjects.

K. Umemura, M. Kanamaru, T. Uematsu, 1994, International journal of clinical pharmacology and therapeutics.

Dihydropyrimidine Dehydrogenase Activity in 150 Healthy Japanese Volunteers and Identification of Novel Mutations

T. Nishiyama, K. Ogura, A. Hiratsuka, 2005, Clinical Cancer Research.

Aldose Reductase Inhibitory and Uricosuric Activities of FK366 in Healthy Volunteers

A. Sugiyama, M. Kanamaru, M. Terakawa, 1993, Journal of clinical pharmacology.

Adenosine A1‐receptor occupancy predicts A1‐receptor antagonist effects of N‐0861

R. Benton, S. Yasuda, R. Woosley, 1998, Clinical pharmacology and therapeutics.

Phase I Study of E1077, a Novel Parenteral Cephem Antibiotic

M. Nakashima, H. Inaba, Y. Tomono, 1994, Journal of clinical pharmacology.

A comparison of the bioequivalence of two formulations of epoetin alfa after subcutaneous injection.

Yasue Kobayashi, A. Togawa, Takanori Tanaka, 2004, British journal of clinical pharmacology.

Clinical Pharmacology Study of C-13 UBT Tablet for the in vivo Diagnosis of Helicobacter pylori Infection

O. Kozawa, H. Matsuno, T. Kawamura, 2002 .